Pleasanton, CA, United States of America

Integenx, Inc.


USPTO Granted Patents = 54

% Expired Patents = 1.9


Trademarks = 2

Forward Citations = 1,047

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Stevan Bogdan Jovanovich (31 out of 54 patents)

silverMedal David A King (23 out of 92 patents)

bronzeMedal Chungsoo Charles Park (19 out of 20 patents)

4.  William D Nielsen (19 out of 30 patents)

5.  Robert A Schueren (13 out of 13 patents)

6.  Ezra Van Gelder (12 out of 14 patents)

7.  Mattias Vangbo (12 out of 12 patents)

8.  David Eberhart (11 out of 17 patents)

9.  Iuliu Ioan Blaga (10 out of 12 patents)

10.  Philip Justus Wunderle (8 out of 9 patents)

11.  Omar EL-Sissi (7 out of 7 patents)

12.  Dennis Lehto (6 out of 23 patents)

13.  Helen Franklin (6 out of 10 patents)

14.  James Klevenberg (6 out of 7 patents)

15.  Michael Recknor (6 out of 7 patents)


Core Competencies:
Biometric Data
Sample Preparation
Microfluidic Devices
Fluidic Cartridges
Electrophoresis
Molecular Analysis
Forensic Files
Universal Systems
Diaphragm Valves
Automated Review
Nucleic Acid Processing
Linear Valve Arrays

54 patents:

Integenx, Inc., based in Pleasanton, California, specializes in advanced biometric data analysis technologies. The company focuses on developing innovative solutions for sample preparation and molecular analysis, utilizing microfluidic devices and fluidic cartridges to enhance the efficiency of forensic investigations. Integenx's core competencies include electrophoresis and the integration of universal systems that streamline the analysis of forensic files, making significant contributions to the field of forensic science and biometrics.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Integenx, Inc.
54 Patents

#16 in Pleasanton, CA

#1,541 in California

#6,549 in US

#13,100 in the World

Pleasanton, CA (US)
Pleasanton, CA, United States of America
Forward Citations = 1,047

53 inventors:

Please report any incorrect information to [email protected]
Loading…